James E. Flynn - 10%+ Owner at ARS Pharmaceuticals, Inc.

Issuer-level insider activity

Role
10%+ Owner
Issuer ticker
SPRY on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by James E. Flynn since 05 Sep 2025

Reported holdings for James E. Flynn in ARS Pharmaceuticals, Inc.

Form 4 holding 10%+ Owner

ARS Pharmaceuticals, Inc.

Security class
Class A Common Stock
Shares / value
4,887,254
Estimated value
$90,218,708
Report date
27 Jun 2025
Price
$18.46
Ownership
Through Deerfield Private Design Fund III, L.P.
Form 4 holding 10%+ Owner

ARS Pharmaceuticals, Inc.

Security class
Class A Common Stock
Shares / value
4,887,254
Estimated value
$90,218,708
Report date
27 Jun 2025
Price
$18.46
Ownership
Through Deerfield Private Design Fund IV, L.P.

Transaction history for James E. Flynn in ARS Pharmaceuticals, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .